| Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke | |
| Zhang, ZY; Shen, CAB; Fang, MQ; Han, YJ; Long, CB; Liu, WH; Yang, M; Liu, M; Zhang, DD; Cao, QQ; Chen, X; Fang, YQ; Lu, QM; Hou, ZL; Li, YX; Liu, ZZ; Lei, X; Ni, HY; Lai, R | |
| 2022 | |
| 发表期刊 | CELLULAR AND MOLECULAR LIFE SCIENCES
![]() |
| ISSN | 1420-682X |
| 卷号 | 79期号:5 |
| 摘要 | Ischemic stroke is a leading cause of death and disability worldwide. Increasing evidence indicates that ischemic stroke is a thromboinflammatory disease in which the contact-kinin pathway has a central role by activating pro-coagulant and pro-inflammatory processes. The blocking of distinct members of the contact-kinin pathway is a promising strategy to control ischemic stroke. Here, a plasma kallikrein and active FXII (FXIIa) inhibitor (sylvestin, contained 43 amino acids, with a molecular weight of 4790.4 Da) was first identified from forest leeches (Haemadipsa sylvestris). Testing revealed that sylvestin prolonged activated partial thromboplastin time without affecting prothrombin time. Thromboelastography and clot retraction assays further showed that it extended clotting time in whole blood and inhibited clot retraction in platelet-rich plasma. In addition, sylvestin prevented thrombosis in vivo in FeCl3-induced arterial and carrageenan-induced tail thrombosis models. The potential role of sylvestin in ischemic stroke was evaluated by transient and permanent middle cerebral artery occlusion models. Sylvestin administration profoundly protected mice from ischemic stroke by counteracting intracerebral thrombosis and inflammation. Importantly, sylvestin showed no signs of bleeding tendency. The present study identifies sylvestin is a promising contact-kinin pathway inhibitor that can proffer profound protection from ischemic stroke without increased risk of bleeding. |
| 收录类别 | sci |
| 语种 | 英语 |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.kiz.ac.cn/handle/152453/13255 |
| 专题 | 科研部门_天然药物功能蛋白质学科组(赖仞) |
| 推荐引用方式 GB/T 7714 | Zhang, ZY,Shen, CAB,Fang, MQ,et al. Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke[J]. CELLULAR AND MOLECULAR LIFE SCIENCES,2022,79(5). |
| APA | Zhang, ZY.,Shen, CAB.,Fang, MQ.,Han, YJ.,Long, CB.,...&Lai, R.(2022).Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke.CELLULAR AND MOLECULAR LIFE SCIENCES,79(5). |
| MLA | Zhang, ZY,et al."Novel contact-kinin inhibitor sylvestin targets thromboinflammation and ameliorates ischemic stroke".CELLULAR AND MOLECULAR LIFE SCIENCES 79.5(2022). |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| 2023032159.pdf(12934KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | 请求全文 | |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论